ADUS

ADUS

USD

Addus HomeCare Corporation Common Stock

$100.580+1.490 (1.504%)

实时价格

Healthcare
Medical Care Facilities
美国

价格图表

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$99.090

最高价

$100.780

最低价

$98.960

成交量

0.00M

公司基本面

市值

1.9B

所属行业

Medical Care Facilities

国家/地区

United States

交易统计

平均成交量

0.23M

交易所

NMS

货币

USD

52周价格范围

最低价 $88.96当前价 $100.580最高价 $136.72

AI分析报告

最后更新: 2025年4月24日
由AI生成数据来源: Yahoo Finance, Bloomberg, SEC

ADUS: Addus HomeCare Corporation Common Stock - What's Happening and What to Watch

Stock Symbol: ADUS Generate Date: 2025-04-24 03:54:56

Alright, let's break down what's been going on with Addus HomeCare stock lately and what the tea leaves seem to be suggesting.

Recent News Buzz

The main chatter around ADUS right now seems pretty positive, at least from one corner of the market. We've seen JMP Securities, an investment firm, come out twice in April (once on the 10th and again on the 22nd) saying they still like the stock a lot. They're sticking with a "Market Outperform" rating, which is basically analyst-speak for "we think this stock will do better than the overall market." Plus, they're keeping a pretty ambitious price target of $150 on it. That's a good chunk higher than where the stock is trading right now.

On a different note, the company itself announced it's going to release its first-quarter earnings results on May 5th. This is a big deal because it's when we'll get the latest official look at how the business is actually performing – things like how much money they made and whether they're growing. Earnings reports can often cause the stock price to jump or drop depending on the results.

So, the news vibe is a mix of positive analyst endorsement and anticipation for the upcoming financial report.

Checking the Price Action

Looking back at the stock's journey over the past few months, it's been quite a ride. Back in late January, shares were trading up around the $125-$130 mark. But then, things took a significant dip through February and March, with the price falling all the way down into the high $80s. That was a pretty rough patch.

However, since hitting those lows in March, the stock has started to climb back up. April has seen a steady recovery, pushing the price back into the $95-$100 range. The last few trading days show the stock hovering right around $98-$99.

Comparing this to the AI's short-term predictions, the AI model seems to think this recent upward trend might continue for a couple more days, predicting small percentage gains for today and the next two days.

Putting It All Together: Outlook & Ideas

Based on what we're seeing – the positive analyst view, the stock's recent bounce off its lows, and the AI's short-term bullish forecast – the immediate picture seems to lean towards the positive side. It looks like the stock is trying to recover some of the ground it lost earlier in the year.

What might this suggest?

  • Near-term leaning: The current situation appears to favor potential buyers or those already holding the stock. The momentum seems to be upward right now.
  • Potential Entry Consideration: If someone were considering getting in, the current price area, maybe around $98 or $99, could be a point to watch. The recommendation data even highlighted entry points around $97.74 and $98.25 recently. This area seems interesting because it's where the stock has been trading after its recent climb.
  • Potential Exit/Stop-Loss Consideration: Managing risk is always key. A potential stop-loss level to consider might be below the recent lows seen in March, perhaps somewhere below $90, or specifically around the $88.15 level mentioned in the recommendation data. This is a point where, if the stock falls below it, the recent recovery trend would likely be broken, suggesting it might be time to cut losses. For taking profits, the AI suggests a potential target around $121.73, while the analyst has a much higher $150 target. These are levels far above the current price, suggesting there could be room to run if the positive trend continues, but they are not guaranteed. The recommendation data also listed a very near-term take-profit at $99.91, which is almost here already.

Remember, the upcoming earnings report on May 5th is a significant event that could change this outlook quickly, depending on the results.

A Little Company Context

Just to keep in mind, Addus HomeCare is in the business of providing care services right in people's homes – things like helping with daily tasks, hospice care, and home health services. They serve a mix of clients, including government programs and insurance companies. So, news about healthcare policies, reimbursement rates, or demand for home-based care can be particularly important for this company's performance. The analyst's positive view and the upcoming earnings report are essentially market opinions and a look at how this specific home care business is navigating its environment.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.

相关新闻

Analyst Upgrades

JMP Securities Reiterates Market Outperform on Addus HomeCare, Maintains $150 Price Target

JMP Securities analyst Nicholas Jones reiterates Addus HomeCare with a Market Outperform and maintains $150 price target.

查看更多
JMP Securities Reiterates Market Outperform on Addus HomeCare, Maintains $150 Price Target
BusinessWire

Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call

Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2025, on Monday, May 5, 2025, after the market

查看更多
Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call
Analyst Upgrades

JMP Securities Maintains Market Outperform on Addus HomeCare, Maintains $150 Price Target

JMP Securities analyst Constantine Davides maintains Addus HomeCare with a Market Outperform and maintains $150 price target.

查看更多
JMP Securities Maintains Market Outperform on Addus HomeCare, Maintains $150 Price Target

AI预测Beta

AI建议

看涨

更新于: 2025年4月27日 20:59

看跌中性看涨

64.5% 置信度

风险与交易

风险等级3/5
中风险
适合于
适中
交易指南

入场点

$100.23

止盈点

$106.96

止损点

$90.48

关键因素

PDI 9.6高于MDI 7.3,且ADX 13.4,表明看涨趋势
当前价格非常接近支撑水平$100.25,表明有强烈的买入机会
交易量是平均值的3.5倍(2,944),表明极强的买入压力
MACD 0.0602低于信号线0.0818,表明看跌交叉

保持更新

设置价格提醒,获取AI分析更新和实时市场新闻。